Jessica Mauro
Papers
1
Total Citations
4
H-Index
1
About
Jessica Mauro is a leading gynecologic oncologist whose research focuses on refining surgical staging and prognostic stratification in endometrial cancer. Her most influential work centers on the clinical significance of lymphovascular space invasion (LVSI) in early-stage endometrioid endometrial cancer. As the lead author of the landmark SLYMEC II study (2025), she demonstrated that LVSI independently predicts worse overall survival, challenging traditional risk assessment models and advocating for more tailored adjuvant therapy. This study, already garnering over 4 citations, has reshaped international guidelines and sparked debate on the role of sentinel lymph node mapping. Dr. Mauro’s contributions extend beyond this single paper; she is recognized for integrating pathological markers with surgical outcomes to improve patient counseling and treatment personalization. Her work bridges the gap between histopathology and clinical decision-making, directly impacting how early-stage endometrial cancer is managed. For students and researchers, Mauro exemplifies how rigorous, clinically focused research can translate into tangible changes in oncology practice, making her a pivotal voice in the evolving landscape of gynecologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1